Product Information
TOPIRAMATE 200 MG TABLET is a generic product labeled by Exelan Pharmaceuticals Inc., priced at $0.1069 per EA under NDC 76282028160. Its NADAC has been published 290 times since Dec 9, 2020.
Strength
200 mg/1
Manufacturer
Exelan Pharmaceuticals Inc.NDC
76282028160
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
TOPIRAMATEApproval Type
Generic (ANDA)
FDA Application
ANDA079162On Market Since
9/7/2020
Pharmacological Classes
Price Statistics
The NADAC for TOPIRAMATE 200 MG TABLET has been published 290 times since Dec 9, 2020, and over the history we have for it it has declined 17.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1069 per EA |
|---|---|
| All-time high | $0.1300 (Jan 13, 2021) |
| All-time low | $0.0880 (Apr 17, 2024) |
| 52-week high | $0.1092 |
| 52-week low | $0.1009 |
| Median price | $0.1069 |
| Average price | $0.1079 |
| Largest weekly change | -19.3% (Apr 17, 2024) |
| Weeks tracked | 290 |
| Tracking since | Dec 9, 2020 |
Generic Alternatives
The matcher finds 12 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 10 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 18% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of TOPIRAMATE 200 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for TOPIRAMATE 200 MG TABLET, manufactured by Exelan Pharmaceuticals Inc., is $0.1069 per EA (NDC 76282028160), effective Jun 24, 2026.
How has the price of TOPIRAMATE 200 MG TABLET changed over time?
Over the history we have for it, the NADAC for TOPIRAMATE 200 MG TABLET has declined 17.0%. It has been tracked across 290 weekly CMS publications since Dec 9, 2020.
What are the highest and lowest recorded NADAC prices for TOPIRAMATE 200 MG TABLET?
Since Dec 9, 2020, the NADAC for TOPIRAMATE 200 MG TABLET has ranged from a low of $0.0880 (Apr 17, 2024) to a high of $0.1300 (Jan 13, 2021), with a median of $0.1069 per EA.
Are there cheaper alternatives to TOPIRAMATE 200 MG TABLET?
Yes. 12 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, TOPIRAMATE 200 MG TABLET, is $0.0880 per EA — about 18% below TOPIRAMATE 200 MG TABLET.
Who manufactures TOPIRAMATE 200 MG TABLET?
TOPIRAMATE 200 MG TABLET (NDC 76282028160) is labeled by Exelan Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification